5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, Switzerland.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Strategies for enriching and characterizing proteins with inhibitory properties on the yeast surface.Protein engineering, design & selection : PEDS · 2023
   Article
2. Production, characterization, and epitope mapping of monoclonal antibodies of ribosomal protein S3 (rpS3).Animal cells and systems · 2021
   Article
3. Disulfide scrambling in IgG2 monoclonal antibodies: insights from molecular dynamics simulations.Pharmaceutical research · 2011
   Article
4. Coupling of aggregation and immunogenicity in biotherapeutics: T- and B-cell immune epitopes may contain aggregation-prone regions.Pharmaceutical research · 2011
   Article
5. Strategies and challenges for the next generation of therapeutic antibodies.Nature reviews. Immunology · 2010
   Review
6. 6th Annual European Antibody Congress 2010: November 29-December 1, 2010, Geneva, Switzerland.mAbs
   Article
7. Biochemical and pharmacological characterization of human c-Met neutralizing monoclonal antibody CE-355621.mAbs
   Article
8. Antibody-drug conjugates: present and future.mAbs
   Article
9. Biosimilar, biobetter and next generation therapeutic antibodies.mAbs
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as